Henderson Jane's Form 4 filing
Apogee Therapeutics, Inc. (APGE) · filed Feb 4, 2026
- Accession no.
- 0001104659-26-010453
- Filed
- Feb 4, 2026
- Trade date
- Feb 2, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $131.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Henderson JaneCIK 0001422304 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Common Stock | SSaleDisposed | −792 | $65.21 | −$51,646.32 | 184,579 | Direct | |
| Feb 2, 2026 | Common Stock | SSaleDisposed | −1,108 | $66.15 | −$73,294.2 | 183,471 | Direct | |
| Feb 2, 2026 | Common Stock | SSaleDisposed | −100 | $66.89 | −$6,689 | 183,371 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.